A single-blind, randomized, placebo-controlled study in healthy men and women to determine the effect of single subcutaneous injections of GSK716155 [albiglutide] on gastric emptying time for solid and liquid components of a meal.
Phase of Trial: Phase I
Latest Information Update: 28 Aug 2017
At a glance
- Drugs Albiglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Oct 2008 Actual start date changed from Nov 2007 to Dec 2007 as reported by Clinicaltrials.gov.
- 18 Aug 2008 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 09 Oct 2007 New trial record.